Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.24.1.u1
Equity (Details) - USD ($)
$ in Thousands, shares in Millions
 1 Months Ended 3 Months Ended
Aug. 11, 2023
Aug. 31, 2020
Mar. 31, 2024
Mar. 31, 2023
Equity [Line Items]        
Net proceeds     $ 14,695 $ 770
Stock Options [Member]        
Equity [Line Items]        
Unrecognized compensation expense     $ 13,200  
Weighted average term     3 years 2 months 12 days  
Compensation expense     $ 1,200 800
Restricted Stock Units [Member]        
Equity [Line Items]        
Weighted average term     1 year 4 months 24 days  
Compensation expense     $ 100 $ 200
Fair value of RSU     $ 1,800  
Vesting period     3 years  
Unrecognized compensation     $ 800  
Capital on Demand Sales Agreement [Member]        
Equity [Line Items]        
Aggregate value of common stock   $ 200,000    
Shares of common stock (in Shares)     1.8 0.1
Gross proceeds     $ 15,000 $ 800
Net proceeds     $ 14,700 $ 800
Common Stock [Member] | Warrant [Member]        
Equity [Line Items]        
Issuance and sale of stock $ 500,000      
Common Stock [Member] | Amended Sales Agreement [Member]        
Equity [Line Items]        
Aggregate value of common stock $ 200,000